Schedule 13G ownership disclosure
GINKGO BIOWORKS HOLDINGS INC
Common Stock · CUSIP: 37611X100
Event date: 2024-12-31
- Filing-level shares
- 24,864,058.00
- Percent of class
- 6.5%
- BAILLIE GIFFORD & CO
Shares: 24,864,058.00 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001088875-25-000019
- Form type
- SCHEDULE 13G/A
- Filer
- BAILLIE GIFFORD & CO
- CIK
- CIK 1088875
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership